Chapter 3 - Antenatal screening services
Scope of antenatal screening
3.1
The antenatal screening of
women and foetuses is an issue generating considerable interest and concern
among consumers, clinicians and health administrators. This interest was
reflected in evidence to the Committee. Major concerns consistently raised in
the evidence relate to the increasing range of screening tests offered to women
and the frequency with which they are performed, the concomitant growth in
expenditure on screening and lack of evidence on the efficacy of many of the
tests now performed. Each of these concerns is discussed in this chapter.
3.2
There is no agreement on the
basic elements of antenatal screening. Some witnesses interpreted antenatal
screening quite narrowly.
Best practice in antenatal (pre-natal) screening standards is
simple and natural. In a healthy woman there is little need for pre-natal
screening - there is no reason to suspect that anything is wrong. At the very
most, women may feel more secure that all is well by conducting checks on urine
contents, blood pressure, weight gain, uterine shape and growth, foetal heart
beat, movement and position, and general nutrition and well-being. Further
screening is unnecessary unless a problem is indicated.[64]
3.3
Others defined it more
explicitly, to encompass psychosocial as well as purely medical risks.
Antenatal screening does not only encompass pathology and
ultrasound testing, but also screening for example domestic violence,
psychosocial conditions, that have major implications for not only the
pregnancy but for the family unit as a whole.[65]
3.4
There is no agreement on the
optimal range and number of screening tests for low risk women.
Currently, no Australian antenatal screening standards exist.
Recommendations regarding screening tests in pregnancy exist, but it appears
from the early work of the Women’s Hospitals of Australia Group, that those
recommendations are interpreted differently across Australia.
Medical and midwifery literature related to antenatal screening tests appears
to be inconclusive and most certainly has not been validated to the Australian
population.[66]
3.5
A number of witnesses focussed
on more recent, technological advances in screening, especially ultrasound. One
witness saw screening as extending to in utero treatment of damaged foetuses.
He chided the Committee for what he saw as its preoccupation with birth
procedures rather than the potentially more rewarding study of in utero
treatment.
Labour and birth are not much of a biological event for the
child. Birth is not an event for the foetal brain. The foetal brain does not
really acknowledge the moment of birth. The foetal brain development has
proceeded a long time before birth and it will proceed a long time after birth
- birth is just another day in its life...we need to appreciate that labour is
not the whole game...
What I am trying to get across is that we need some lateral
thinking. Instead of having an entire inquiry based on birthing procedures, we
need to understand that it is not the main game. The main game from government
should be to de-focus off the moment of birth and to start focusing on the
amazing opportunities we have to improve the life of our community by steps at
earlier times.[67]
3.6
While acknowledging the
emergence of foetal research and treatment in utero, the Committee is not
persuaded by Professor Newman’s claims, neither his assessment of the limits of
its Inquiry nor of the insignificance of birth for the foetus.
3.7
The Committee accepts that
antenatal screening refers to the tests and examinations offered to pregnant
women, which range from straightforward measurement of blood pressure and
determination of blood type through to very sophisticated ultrasound screening,
for example nuchal fold screening.
3.8
Despite the range of views on
antenatal screening procedures however, there was substantial agreement, at
least among clinicians, on routine procedures to establish health status,
enabling corrective action to be taken where appropriate. The Royal Australian College of
General Practitioners, for example, advised:
Generally accepted antenatal screening procedures include:
Routine blood and urine tests for blood group, anaemia, tests
for preventable or treatable conditions such as rubella, syphilis, Hepatitis B
and identification of diseases such as HIV or Hepatitis C. Routine anatomy
ultrasound at 18 weeks gestation is accepted practice.[68]
3.9
The Royal Australian and New
Zealand College of Obstetricians and Gynaecologists suggested the following
(broadly similar) base line investigations in apparently normal pregnancies, to
be carried out at the first antenatal visit.
Tests
at first antenatal visit:
- Blood
group and antibody screen
- Full
blood picture
- Rubella
antibody status
- Syphilis
serology
- Hepatitis
B serology
- Hepatitis
C serology
- HIV
serology
- Cervical
cytology[69]
3.10
Despite the guidelines issued
by the Royal Australian and New Zealand College of Obstetricians and
Gynaecologists, referred to above, which recommend that screening for HIV
should be universally provided to pregnant women, it is not routine practice to
provide it. Practice varies from one
institution to another and from one practitioner to another. Women’s Hospitals
Australia, for example, advised of significant variations between its member
hospitals.[70]
3.11
There was much less agreement on a range of other
tests such as short glucose tolerance tests for gestational diabetes, as
indicated in the following excerpts from submissions to the Committee.
An entire medical history has grown up around diagnosing and
treating gestational diabetics in the belief that in doing so it will improve
outcomes for mothers and their babies. The exact reverse may in fact be the
reality. We need to challenge the gestational diabetes ‘gravy train’ and
accurately reveal the costs of routine screening. ‘Large amounts of money and
resources that are tied up in diagnosing and treating this ‘condition’ could be
diverted into areas where they might be more effective’.[71]
* * *
A review of antenatal screening was performed at Monash Medical
Centre and certain recommendations were made, including the removal of
screening for gestational diabetes on all.
It was proposed to screen only those women considered at high risk for
gestational diabetes and those women showing glucose in their urine...The policy
for screening all women [for gestational diabetes] was in situ and as the
senior obstetricians had opposing viewpoints the policy in situ remained. This
suggests that it is easy to introduce policies that increase interventions but
more difficult to show evidence to remove them.[72]
3.12
Witnesses from Women’s Health Australia
advised that screening for gestational diabetes is currently the subject of a
comprehensive National Institute of Health (America)
study which may provide more definite answers to the unresolved question of
whether this intervention can be justified as part of routine screening.[73]
3.13
The Committee was advised that
at present there was considerable variation in the usage of tests for
gestational diabetes, whereas the routine tests referred to earlier were offered
almost universally to pregnant women.
3.14
Several witnesses pointed out
that non standard tests were more beneficial if selectively applied to at risk
populations rather than universally applied.
The decision to implement or suspend antenatal screening is
related to the setting of the antenatal care. Whilst all women must have equal
access to quality care, regardless of their geographic location or insurance
status, what defines that quality may vary depending on the local incidence of
disease, the ethnic mix of the local population, and whether the intervention
used is Medicare rebatable.[74]
3.15
Widely different views were
also presented to the Committee on the value of antenatal screening of any kind
for low risk women. Some witnesses considered it unnecessary, as indicated in
the submission from the Queensland Home Midwifery Association quoted earlier in
this chapter.
3.16
Others believed antenatal
screening an essential contributor to Australia’s
enviable record on childbirth outcomes.
Current data suggests that there is correlation between the
provision of antenatal services and screening with improved childbirth
outcomes. (indicated by morbidity and mortality figures). Whilst it is widely
accepted that there is benefit derived from the provision of antenatal care and
screening, there is not, as yet, a consensus as to what constitutes “best
practice”.[75]
3.17
The Committee supports a
definition of antenatal screening which includes basic, routine tests and
measurements such as blood pressure and haemoglobin counts as well as more
sophisticated tests such as ultrasound. The Committee is convinced of the
importance of screening in improving outcomes for mothers and babies.
3.18
In evidence to the Committee,
and in the literature generally, most concerns about antenatal screening have
focussed on ultrasound scanning.
Ultrasound scanning
3.19
Ultrasound techniques were
first developed in the 1950s to examine babies in utero. Their use has since
become almost universal in Australia.
In a 1994 Australia’s
Parents survey, 99.5% of respondents reported having at least one ultrasound in
their last pregnancy.[76]
3.20
They absorb a significant
proportion of the medical costs associated with childbirth. The Committee
received many comments on this issue.
Ultrasound is like a vast, bottomless pit.[77]
* * *
We spend more on taking pictures of babies than we do on
delivering them.[78]
* * *
It does concern me that too much ultrasound is undertaken in
pregnancy... diagnostic ultrasound HIC costs more than the whole of obstetric
services - not just antenatal care, but antenatal care, confinement and
postnatal care. That was two years ago.[79]
* * *
Figures from the Health Insurance Commission show the cost of
obstetric ultrasound for 1997/8 was $39 million. Total number of obstetric
ultrasounds 472 026 for 280 000 births. Cost of all other obstetric care from
MBS obstetric items was $54 million. On top of this there will be
underestimates, as they do not include the private fee on top of medicare which
can be the same again, or more.[80]
3.21
The most recent figures from
the Health Insurance Commission, which exclude services provided by hospital
doctors to public patients in public hospitals, show that in the period July
1998 to June 1999 expenditure was:
-
$38.6 million on ultrasound (almost all of it
routine scanning);
-
$27.6 million on labour and delivery (including
complex births, Caesarean sections and immediate post natal care); and
-
$30 million on antenatal visits.[81]
3.22
The increase in the number of
ultrasound tests performed, and the concomitant rise in costs, is especially
troubling to some.
Of particular concern is the cost of numerous ultrasound
examinations. It is our current experience that it is not unusual for women to
have undergone three ultrasound examinations before their pregnancy reaches
twenty weeks of gestation.[82]
3.23
There is no clear evidence of
what has caused the dramatic increase in ultrasound screening. Fear of
litigation on the part of clinicians seems to be a significant contributing
factor.
Of particular concern to all parents is the risk of an
abnormality in their baby. Consumer demand for reassurance in this regard is
becoming overwhelming and the birth of an undetected abnormal child may often
be followed by attempts at litigation. Failure to perform an ultrasound,
cardiotocograph or other medical tests at an appropriate time are commonly
cited in writs against doctors, midwives and hospitals.
The adverse medico-legal climate in Australia
has created a drift to a much more defensive style of medical practice with a
greater need to demonstrate reassuring negative test results to consumers.[83]
3.24
The increasing use of
diagnostic ultrasound in pregnancy parallels its increasing use more generally.
There has been continuous (nominal) growth in the use of
ultrasound. In 1990-91, 77 ultrasound services were claimed for every 1000
persons, by 1996-97 this rate had increased to 139 per 1000 persons. For the
last seven years (1990-91 to 1996-97), there has been an average annual growth
rate of 10.4 per cent in ultrasound services per 1000 population compared with
a rate of 2.7 per cent for all diagnostic imaging services [including
radiology, nuclear medicine etc].[84]
3.25
The growth in routine
ultrasound screening is of particular concern given the lack of consensus on
its value.
3.26
There is no doubt that
ultrasound is beneficial where difficulties are identified or suspected, for
example when bleeding occurs early in pregnancy or a breech position is
suspected. Accurate dating through ultrasound may be helpful in preventing
unnecessary induction of birth and in ensuring that other screening tests are
performed at a time when they will provide the most accurate results.
3.27
The value of routine ultrasound
scanning is more controversial. Some witnesses before the Committee believed
ultrasounds are no more accurate in determining due date than are women
themselves, or their doctors or midwives. Others questioned their accuracy in
detecting foetal abnormalities. Whilst ‘ultrasound is regarded as the gold
standard for the establishment of the viability of pregnancy’ its accuracy in
determining physical abnormalities is very questionable.[85] Scans do not generally identify
intellectual disabilities.
While many women are reassured by a normal scan, in fact RPU
[routine prenatal ultrasound] detects only between 17% and 80% of the 1 in 50
babies that have major abnormalities at birth. A recent Brisbane
study showed that ultrasound at a major women’s hospital missed around 40% of
abnormalities, with many of these being difficult or impossible to detect.[86]
* * *
Despite this epidemic of ultrasound examinations, which are
supposed to give reassurance, at least one in five perinatal deaths are
associated with lethal anomalies, many - if not most of which - are diagnosable
by ultrasound.[87]
3.28
In the view of the Australian
Health Technology Advisory Committee the accuracy of the ultrasound test is
related to the training and expertise of the operator (normally a radiologist)
in conducting the test and the skill and practice of the physician in
interpreting it. Staff in major centres with high exposure to foetal
abnormalities have greater detection rates than staff in centres conducting
fewer tests.[88] The Committee was
concerned to learn that there are currently no standards governing the training
of those who operate ultrasound equipment, a situation which it considers
unacceptable given the number of tests performed, their cost and the impact on
women and their families of inaccurate diagnoses.
3.29
Inaccuracy in determining abnormalities
is not the only concern. Another is the fact that for the majority of
abnormalities detected, there is no possibility of remedial treatment. A
further concern is that in a small number of cases false positive diagnoses are
made, where the baby is said to be damaged when it is in fact normal. In a
greater number of cases, (possibly up to 10%)[89]
scans are unclear. In each of these situations families must endure months of
needless anxiety. In some instances normal babies have been aborted because of
false-positive diagnoses.
We generate an enormous amount of anxiety by some of these
screening tests and I am not sure that all of them are actually worth while.[90]
* * *
Most women choose to have prenatal diagnosis, because they want
the reassurance that their baby is normal. However our current tests cannot
give this guarantee. Perhaps we are expecting too much of this technology, and
in our striving for the perfect baby, we are producing a system that has its
own share of heartache.[91]
3.30
A more realistic expectation of
what can be achieved, and its costs as well as its benefits, would assist in
considering future priorities and directions for antenatal screening.
3.31
There appears to be inadequate
counselling of women about the nature of a screening test. Women are often not
aware of the possible adverse consequences of routine scanning, and the
difficult decisions they may face as a result of it.
I find that most women, once aware of the likelihood of false
positive or false negative results with regard to ultrasound do not want the
screening. My impression of the general public is that they are very poorly
informed about ultrasound and that it is becoming a part of culture that there
is a photo of the baby before birth.[92]
3.32
Evidence to the Committee
suggests that the position in Australia
is fast approaching that in the United States where a 1993 editorial in U.S.A. Today proclaimed:
Baby’s first picture...a $200 sonogram shot in the womb...is a nice
addition to any family album.[93]
3.33
There are growing concerns in
the medical profession about the safety of ultrasound for mother and baby,
although there is no conclusive evidence to support the case for suspension or
limitation of routine tests. Concerns are heightened by the absence of
standards in Australia governing the level of the dose used in ultrasound scans (which may
vary by up to 5,000 times according to the machine used) and the training of
operators. Since the level of the dose used does not affect the accuracy of
ultrasound results, the Committee considers that standards governing the safety
of ultrasound equipment should be introduced without delay.
3.34
Despite these concerns, routine
ultrasound scanning (one scan at 18 weeks) remains almost universal. Evidence
to the Committee suggested few variations in this practice between hospitals,
States, or public and private patients. However, there is a much greater
variation in the multiple use of ultrasound scans and in the use of more
sophisticated ultrasound scans.
3.35
A very large randomised study
in the United States (the RADIUS trial) involving 15,151 pregnant women at low risk for
perinatal problems, to determine the impact of ultrasound screening on
perinatal outcomes concluded:
Potential benefits such as satisfying patients’ desires for
assurance that there are no fetal anomalies must be weighed against the
unnecessary anxiety entailed in the examinations and the risks of overtreatment
due to false positive diagnoses. The adoption of routine ultrasound screening
in the United States
would add considerably to the cost of care in pregnancy, with no impact on
perinatal outcome.[94]
3.36
An analysis of nine trials
undertaken through the Cochrane Pregnancy and Childbirth Group trials
concluded:
Routine ultrasound in early pregnancy appears to enable better
gestational age assessment, earlier detection of multiple pregnancy and earlier
detection of clinically unsuspected fetal malformation at a time when
termination of pregnancy is possible. However the benefits for other
substantive outcomes are less clear.[95]
3.37
The only large, randomised
study undertaken in Australia, the Raine study, compared the effects on children of mothers who
had had a single ultrasound at 18 weeks with the children of those mothers
who had had five ultrasounds. It showed no long term, demonstrable adverse
effects.
It was the world’s only randomised trial of multiple ultrasounds
in pregnancy that has ever been performed. It showed that there were no
deleterious effects on the children whatsoever, apart from a one per cent shift
in the birth weigh curve to the left in the babies that had had frequent
ultrasounds. In other words, about a 30 gram overall reduction...By one year of
age, the effect had gone.[96]
3.38
The Committee considers that
routine ultrasound screening in pregnancy is an obvious area for the
development of evidence based guidelines which will minimise unnecessary
testing without compromising maternal or foetal health and ensure that funds
are directed to areas of maximum benefit to the health of mother and child.
Many submissions pointed to the need for such guidelines, and for further
research on which to base them. This issue will be discussed in a later
chapter, as one aspect of best practice guidelines in antenatal care.
Recommendation
The Committee RECOMMENDS that the National Health and Medical
Research Council develop standards for the training of operators of all
obstetrical ultrasound equipment and for those who interpret the results of
those tests.
Recommendation
The Committee RECOMMENDS that the National Health and Medical
Research Council develop guidelines governing the safe use of all obstetrical
ultrasound equipment.
Recommendation
The Committee RECOMMENDS that the National Health and Medical
Research Council develop or coordinate the development of evidence based
assessments of the efficacy of routine ultrasound scanning in pregnancy and
that it conduct a cost benefit analysis of current ultrasound practices.
3.39
Although most evidence to the
Committee on high technology antenatal screening focussed on routine ultrasound
screening, other antenatal tests were also discussed. Those receiving most
attention are described below.
Nuchal fold test
3.40
The nuchal fold test, also
known as the nuchal translucency test, is a relatively new, specialised
ultrasound screening test, performed at 11 - 13 weeks, to measure the fluid
level at the back of the neck of the foetus. Babies with extra fluid have a
higher risk of Down’s Syndrome. In cases where this is suspected after
ultrasound, mothers may be offered amniocentesis or chorionic villus sampling (CVS)
for chromosomal analysis.
3.41
Similar concerns have been
raised in connection with the nucal translucency test as with ultrasound. These
include: inaccuracies in results; insufficient training of those who operate
the equipment and those who interpret the results; the impact on women of false
positive diagnoses, especially for those women who have received inadequate
counselling and information before undertaking the procedure; and its costs.
All of these concerns were raised in a submission from the NSW Midwives
Association.
More recently, the widespread use of ultrasound for screening
women for Down Syndrome using the Nuchal Translucency test has emerged. This is
increasingly being offered to women regardless of their age or risk factors.
Often they are not adequately informed of the subsequent investigations that
may need to follow, such as amniocentesis with its inherent complications. The
high false positive rate of Nuchal Translucency testing is well known. Many
untrained practitioners are beginning to use this technique because of the
potential financial gains. Once again, we are not evaluating a technology
before implementing it and like so many interventions in childbirth, once the
procedure is established it is impossible to withdraw it.[97]
3.42
The disturbingly high rate of
false positive results from nuchal translucency testing, and its deleterious
consequences for the women and families concerned, were highlighted in a recent
article by Dr Sarah Buckley.
With Nuchal translucency, for example, 19 out of 20 women who
get a “positive” result will not have been carrying an affected baby, but will
go through counselling and amniocentesis (with a 1% risk of miscarriage), and
then wait for days or weeks before reassuring results are back. Some women who
have been through this experience report that they felt anxious about their
baby even after this reassurance, and others believe that it has permanently
affected their relationship with their child.[98]
3.43
Suggestions for controlling the
growth in nucal fold screening were made in a submission from the Director of
Obstetrics and Gynaecology at Queen Elizabeth Hospital in South Australia.
There should be support for an Australian multicentre trial of
nuchal fold screening; otherwise it will creep in by stealth with no adequate
quality control. One could mount an argument for certified training in the
technique (which is available) before allowing a charge on Medicare to be made.[99]
3.44
The Committee believes there is
merit in this suggestion and that it should be further investigated.
3.45
The nuchal translucency test,
because it requires sophisticated equipment, is generally not available to
women outside major metropolitan centres.
This latest form of screening [nuchal fold] has been introduced
and now appears to be a part of “routine screening”. It appears that this
sophisticated screening tool is primarily available to women in most urban
areas. The question that must be asked, is whether there is equity of access to
this screening for the majority of women in Australia?[100]
Recommendation
The Committee RECOMMENDS that the National Health and Medical
Research Council conduct or oversee the conduct of an Australian multicentre
trial of nuchal fold screening to determine its efficacy for use among pregnant
women generally, and among those considered at particular risk of carrying
babies with Down’s Syndrome.
Recommendation
The Committee RECOMMENDS that earlier recommendations relating
to the training of operators and the regulation of equipment used in routine
ultrasound screening should also apply to nuchal fold screening.
Maternal serum screening (MSS)
3.46
This is a blood test undertaken
at 15-18 weeks of gestation and designed to detect babies at high risk of
Down’s Syndrome and neural tube defects such as spina bifida. The accuracy of
the test is severely compromised in cases in which exact gestational age is in
doubt. This is one reason given as justification for the increasing number of
ultrasounds being performed early in pregnancy. Accurate determination of
foetal age, it is claimed, can ensure that other tests are performed at a time
when their accuracy is maximised.
3.47
The tests were developed as one
means of ensuring that only those babies most likely to have an abnormality
would be subjected to amniocentesis and CVS tests, which carry a chance of
miscarriage. (There is a 1% chance in the case of amniocentesis, for example).
Again, similar concerns were raised with the Committee as in the case of the
other screening tests discussed. Inadequate information to women undertaking
the test was a particular concern for MSS.
Many of the informed consent problems with Ultrasound apply to
prenatal diagnosis, and particularly MSS, where the blood test may be taken as
part of the standard pregnancy screen, without the necessary counselling and
discussion.[101]
3.48
Rates of MSS are very variable
between States.
Each State coordinates its own blood testing, or maternal serum
screening (MSS), and rates vary from state to state - eg around 75% in S.A. and
about 20% in Victoria, depending on the enthusiasm of the institution involved.[102]
Amniocentesis and chorionic villus sampling (CVS)
3.49
These are diagnostic tests
rather than screening tests like ultrasound. They can therefore determine with
certainty whether the foetus has the abnormality for which it is being tested.
3.50
Each of these tests is used to
determine whether the foetus has Down’s Syndrome or other chromosomal
abnormalities. In the case of amniocentesis, a sample of the amniotic fluid
which surrounds the baby is withdrawn for examination. In the case of CVS a small
fragment of the placenta is removed. This test is preferred by some women
because it can be conducted at 10-12 weeks when, in the event of a positive
diagnosis, an early termination is possible.
3.51
This discussion of antenatal
screening has been confined to the tests in common use, and about which the
greatest concern has been expressed. The Committee received little information
on other tests, such as genetic tests for families at risk of specific
inherited conditions.
Navigation: Previous Page | Index | Next Page